FDA Inspection
Dariusz Kowalski, M.D.Dariusz Kowalski, M.D. – FDA Inspection, Mar 13, 2015
Record Details
This FDA Inspection record concerns Dariusz Kowalski, M.D., with an inspection on March 13, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Dariusz Kowalski, M.D.
- Inspection Date
- March 13, 2015
- Product Type
- Drugs
View Company Profile
ID · de03a9f4-5ee1-481c-bb75-a14b63678f08
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 927597
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dariusz Kowalski, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2025 | Not classified | Office of Inspections and Investigations |
Other documents for Dariusz Kowalski, M.D.
- FDA Inspection 1273215 - 2025-06-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.